Adagio Therapeutics Inc ADGI:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:57 PM EDT
4.46quote price arrow up+0.26 (+6.19%)
Volume
60,818
Close
4.20quote price arrow down-0.31 (-6.87%)
Volume
1,305,052
52 week range
2.41 - 78.82
Loading...
  • Open4.40
  • Day High4.77
  • Day Low4.20
  • Prev Close4.51
  • 52 Week High78.82
  • 52 Week High Date11/30/21
  • 52 Week Low2.41
  • 52 Week Low Date06/15/22

Key Stats

  • Market Cap457.09M
  • Shares Out108.83M
  • 10 Day Average Volume0.88M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-42.15

KEY STATS

  • Open4.40
  • Day High4.77
  • Day Low4.20
  • Prev Close4.51
  • 52 Week High78.82
  • 52 Week High Date11/30/21
  • 52 Week Low2.41
  • 52 Week Low Date06/15/22
  • Market Cap457.09M
  • Shares Out108.83M
  • 10 Day Average Volume0.88M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-42.15

RATIOS/PROFITABILITY

  • EPS (TTM)-3.15
  • P/E (TTM)-1.33
  • Fwd P/E (NTM)-2.66
  • EBITDA (TTM)-295.986M
  • ROE (TTM)-218.40%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/15/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Adagio Therapeutics Inc

There is no recent news for this security.

Profile

MORE
Adagio Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of differentiated products for the prevention and treatment of infectious diseases. Its product candidate, adintrevimab, for the prevention and treatment of coronavirus disease 2019 (COVID-19), the disease caused by the virus SARS-CoV-2 and its variants. The Company has a clinical program with a Phase I healthy volunteer single...
Marc Elia
Chairman of the Board
David Hering
Chief Executive Officer, Director
Jane Henderson
Chief Financial Officer, Chief Business Officer
Rebecca Dabora Ph.D.
Chief Technology and Manufacturing Officer
Address
1601 Trapelo Road, Suite 178
Waltham, MA
02451
United States

Top Peers

SYMBOLLASTCHG%CHG
ALDX
Aldeyra Therapeutics Inc
6.94-0.04-0.57%
BTAI
BioXcel Therapeutics Inc
14.44-0.22-1.50%
GBIO
Generation Bio Co
5.23-0.76-12.69%
VRDN
Viridian Therapeutics Inc
23.58+0.33+1.42%
PRLD
Prelude Therapeutics Inc
8.45-0.07-0.82%